+612 9045 4394
 
CHECKOUT
Endocrine Therapies in Breast and Prostate Cancer : Cancer Treatment and Research - C. Kent Osborne

Endocrine Therapies in Breast and Prostate Cancer

Cancer Treatment and Research

By: C. Kent Osborne (Editor)

Hardcover

Published: June 1988
Ships: 7 to 10 business days
7 to 10 business days
RRP $631.99
$437.75
31%
OFF
or 4 easy payments of $109.44 with Learn more
if ordered within

Other Available Formats (Hide)

  • Paperback View Product Published: 5th October 2011
    Ships: 7 to 10 business days
    7 to 10 business days
    $331.80

It has been recognized for many years that cancers originating in the breast and prostate gland are frequently 'endocrine-dependent. ' Traditional thera- pies included surgical endocrine ablative procedures or pharmacologic hor- mone administration, both designed to antagonize the stimulatory effects of sex steroid hormones. In the past decade, several new treatment strategies for these tumors have emerged from basic studies in reproductive biology and mechanisms of action of steroid hormones. In some instances, these new treatments have elimin- ated or reduced the need for major surgical ablative procedures or for toxic hormone therapy. The clinical role for other new treatments has not yet been clearly defined, although exciting preliminary data from recent clinical trials are now available. Thus, an objective review of the current status of these new therapeutic approaches is of interest. In this volume we have attempted to provide an in-depth review of both basic and clinical research involving several new treatment strategies for breast and prostate cancer. The first three chapters summarize preclinical and clinical studies of the luteinizing hormone-releasing hormone analogues, which can be used effectively to induce 'medical castration. ' Chapters 4, 5, and 6 review the rationale and clinical use of the compounds known collec- tively as the aromatase inhibitors, which can also be used to suppress sex steroid hormone levels. Antiestrogen mechanism of action and its clinical implications for the design of innovative treatment approaches is considered in chapters 7 and 8.

1. Preclinical Studies and Antitumor Mechanism of Action of Luteinizing Hormone-Releasing Hormone Analogues.- 2. Luteinizing Hormone-Releasing Hormone Analogues in the Treatment of Prostate Cancer.- 3. Luteinizing Hormone-Releasing Hormone Agonists in the Treatment of Breast Cancer.- 4. Aromatase Inhibitors as New Endocrine Therapy for Breast Cancer.- 5. Clinical Use of Aromatase Inhibitors in the Treatment of Breast Cancer.- 6. Aminoglutethimide: Theoretical Considerations and Clinical Results in Advanced Prostate Cancer.- 7. Antiestrogen Therapy for Breast Cancer: Current Strategies and Future Prospects.- 8. Effects of Estrogens and Antiestrogens on Cell Proliferation: Implications for the Treatment of Breast Cancer.- 9. Flutamide and Other Antiandrogens in the Treatment of Advanced Prostatic Carcinoma.- 10. Progestational Agents in the Treatment of Breast Cancer.

ISBN: 9780898383652
ISBN-10: 089838365X
Series: Cancer Treatment and Research
Audience: Professional
Format: Hardcover
Language: English
Number Of Pages: 162
Published: June 1988
Publisher: Kluwer Academic Publishers
Country of Publication: US
Dimensions (cm): 23.5 x 15.5  x 1.1
Weight (kg): 0.96